The TB Vaccine Accelerator, a program to strengthen the pipeline of tuberculosis (TB) vaccine candidates and enable a more rational and accelerated vaccine development process, is launching a grant opportunity that is part of the Grand Challenges in Global Health—a large set of grant programs aimed at overcoming persistent bottlenecks that prevent the creation of effective health solutions for the developing world.
This grant opportunity, the first public request for applications (RFA) launched by the TB Vaccine Accelerator, focuses on two interrelated program goals: